Actively Recruiting
Virtual Reality for Pain Management During Dupilumab Injection
Led by St. Justine's Hospital · Updated on 2025-08-24
98
Participants Needed
2
Research Sites
189 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this within-subject randomized study is to examine the efficacy of a VR immersive game for pain and anxiety management of children during the subcutaneous injection of dupilumab for moderate to severe atopic dermatitis. We will recruit children from 6 to 17 years. The main research question is: 1. Does VR immersive game will generate less anxiety and pain than standard procedures, for children receiving dupilumab injection for moderate to severe atopic dermatitis? 2. Does the occurence of side effects is similar between both study groups? Participants will be randomized according to either sequences: VR-Standard care or Standard care-VR. During the VR sequence, participants will be playing the VR immersive game during the injection. During the Standard care sequence participants will not benefit from any pain management but passive distraction tools will be offered (and documented) to children. The investigators will take measures of pain and anxiety, using validated scales, before and after the procedures at each sequence.
CONDITIONS
Official Title
Virtual Reality for Pain Management During Dupilumab Injection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between the ages of 6 to 17 years old
- Diagnosed with moderate to severe atopic dermatitis and receiving or about to start subcutaneous dupilumab injections
- Presence of a consenting parent who understands, reads, and writes French or English
You will not qualify if you...
- Diagnosed cognitive impairment that prevents playing a virtual reality game
- Epilepsy diagnosis
- Inability to sit during the procedure with at least a 30-degree head angle required for VR use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
St. Justine's Hospital
Montreal, Quebec, Canada, H1T 3C5
Actively Recruiting
2
CHU Sainte-Justine
Montreal, Quebec, Canada, H3T 1C5
Actively Recruiting
Research Team
S
Sylvie Le May, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here